Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Lymph Node Metastases in Diffuse Malignant Peritoneal Mesothelioma
Annals of Surgical Oncology, 10/28/09
Baratti D et al. – Pathologically negative nodes (as compared with pathological positive and not assessed), along with pathological and biological features, independently correlated with increased survival following comprehensive treatment. This suggests the need for careful node sampling when performing surgical cytoreduction for DMPM patients.
Related Articles
Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature
World Journal of Surgical Oncology, 11/12/09
Relevance Score: 90%
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09
Relevance Score: 88%
Living with mesothelioma. A literature review
European Journal of Cancer Care, 10/27/09
Relevance Score: 87%
Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma
American Journal of Surgical Pathology, 10/27/09
Relevance Score: 87%
Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
Lung Cancer, 10/01/09
Relevance Score: 85%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Variations in gastric cancer care
Cancer, 12/11/09
Extracapsular lymph node spread
Cancer, 12/11/09
Folate intake, post–folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
American Journal of Clinical Nutrition, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


